Kevin D. Benson

Kevin D. Benson

Obstetrics and Gynecology
800 Oak St.
Sheldon, IA 51201

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.

Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.

Journal: The Journal of urology
Published: April 13, 2026

Implantable Tibial Neuromodulation Therapy Improves Symptoms of Urge Urinary Incontinence From the TITAN 2 Pivotal Study.

Implantable Tibial Neuromodulation Therapy Improves Symptoms of Urge Urinary Incontinence From the TITAN 2 Pivotal Study.

Journal: The Journal of urology
Published: January 26, 2026

Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.

Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.

Journal: Toxins
Published: March 13, 2025

Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence.

Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence.

Journal: The Journal of urology
Published: November 25, 2024

Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.

Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.

Journal: Neurourology and urodynamics
Published: May 26, 2024

A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.

A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.

Journal: Neurourology and urodynamics
Published: January 03, 2024

Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation device.

Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation device.

Journal: Contemporary clinical trials communications
Published: May 15, 2023

Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.

Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.

Journal: Neurourology and urodynamics
Published: October 23, 2020

One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.

One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.

Journal: Neurourology and urodynamics
Published: January 22, 2020

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: October 04, 2019

Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.

Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.

Journal: The Journal of urology
Published: July 27, 2019

Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.

Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.

Journal: The Journal of urology
Published: April 09, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026